NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.85% | -6.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.85% | -6.73% | |||
| Cost of Revenue | 3.71% | -4.71% | |||
| Gross Profit | 9.96% | -14.79% | |||
| SG&A Expenses | 7.48% | 0.32% | |||
| Depreciation & Amortization | -0.36% | 4.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.11% | -3.74% | |||
| Operating Income | 92.99% | -80.16% | |||
| Income Before Tax | 48.57% | -163.52% | |||
| Income Tax Expenses | -30.71% | -20.95% | |||
| Earnings from Continuing Operations | 45.69% | -189.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 18.88% | -18.67% | |||
| Net Income | 40.48% | -235.92% | |||
| EBIT | 92.99% | -80.16% | |||
| EBITDA | -26.58% | -43.97% | |||
| EPS Basic | 40.38% | -236.84% | |||
| Normalized Basic EPS | 83.33% | -156.25% | |||
| EPS Diluted | 57.53% | -292.11% | |||
| Normalized Diluted EPS | 83.33% | -156.25% | |||
| Average Basic Shares Outstanding | 0.01% | 0.15% | |||
| Average Diluted Shares Outstanding | -0.35% | -0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||